1. Yin, Chunzhao, Zhang, Cunzhen, Wang, Yongqiang, Tao, Yongzhen, Yin, Huiyong. 2023. ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis. In Hepatology (Baltimore, Md.), 81, 77-93. doi:10.1097/HEP.0000000000000704. https://pubmed.ncbi.nlm.nih.gov/38051951/
2. Niu, Lili, Geyer, Philipp E, Wewer Albrechtsen, Nicolai J, Hofmann, Susanna M, Mann, Matthias. 2019. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. In Molecular systems biology, 15, e8793. doi:10.15252/msb.20188793. https://pubmed.ncbi.nlm.nih.gov/30824564/
3. Liu, Guijun, Wang, Ningning, Zhang, Cunzhen, Tao, Yongzhen, Yin, Huiyong. 2021. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis. In Hepatology (Baltimore, Md.), 74, 3037-3055. doi:10.1002/hep.32064. https://pubmed.ncbi.nlm.nih.gov/34292642/
4. Zhao, Nannan, Xu, Haixu. . Pan-cancer analysis of aldolase B gene as a novel prognostic biomarker for human cancers. In Medicine, 102, e33577. doi:10.1097/MD.0000000000033577. https://pubmed.ncbi.nlm.nih.gov/37083815/
5. Beyzaei, Zahra, Ezgu, Fatih, Imanieh, Mohammad Hadi, Honar, Naser, Geramizadeh, Bita. 2023. Identification of a novel mutation in the ALDOB gene in hereditary fructose intolerance. In Journal of pediatric endocrinology & metabolism : JPEM, 36, 331-334. doi:10.1515/jpem-2022-0566. https://pubmed.ncbi.nlm.nih.gov/36659819/
6. Liu, Xianxian, Xin, Siming, Zheng, Jiusheng, Zou, Yang, Lai, Hua. 2023. Associations between ALDOB polymorphisms and intrahepatic cholestasis of pregnancy susceptibility in the Chinese Han population. In Ginekologia polska, 95, 132-142. doi:10.5603/gpl.92931. https://pubmed.ncbi.nlm.nih.gov/37743645/
7. Li, Xiao-Yang, Xu, You-Yao, Wu, Sen-Yan, Zhou, Yan, Cheng, Guo-Bin. 2024. Identification of ALDOB as a novel prognostic biomarker in kidney clear cell renal cell carcinoma. In Heliyon, 10, e29368. doi:10.1016/j.heliyon.2024.e29368. https://pubmed.ncbi.nlm.nih.gov/38655323/
8. Shao, Yuan, Wu, Bo, Yang, Zhen, Wang, Yong, Niu, Yuanjie. . ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma. In Translational andrology and urology, 12, 549-571. doi:10.21037/tau-22-743. https://pubmed.ncbi.nlm.nih.gov/37181232/
智鼠故事 
